News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Regulators

Regulatory Updates

FDA, EMA, PMDA, MHRA, and global regulatory coverage in one crawlable hub.

Open hub

Trials

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Open hub

Pipeline

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Open hub

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

daily refresh

Coverage

Latest indexed stories

8,237 stories indexed, page 46 of 138

🌍Apr 17Industryenanta.com

Featured signal

Oral STAT6 Inhibitor EPS-3903 Demonstrates Good Preclinical In Vivo Tolerability Without Reactive Metabolites or Metabolic/Safety Liability In Vitro or In Vivo

Publisher

Enanta Pharmaceuticals

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

Enanta PharmaceuticalsOriginal publisher link

Canonical metadata stays public, while full text remains on the original site.

🌍Apr 16Industrycellculturedish.com

Integrating Cleavage, Deprotection, and TFF: How Asahi Kasei’s THESYS® Platform Is Reshaping Oligonucleotide Manufacturing

The Cell Culture DishOriginal source

🇺🇸Apr 16CDMOcookmedical.com

Cook Research Incorporated earns first-of-its-kind ISO certification in the U.S.

Cook PharmicaOriginal source

🇯🇵Apr 16Researchriken.jp

Verification Committee Report Regarding a Media Report on RIKEN

RIKENOriginal source

🌍Apr 16Researchuab.edu

Can GLP‑1 medications increase kidney stone risk? A UAB urologist offers insight

University of Alabama at BirminghamOriginal source

🇺🇸Apr 16Researchnews.nm.org

Volunteers Provide Compassion and Service, Impacting the Lives of those who Give and Receive Care

Northwestern MedicineOriginal source

🇪🇸Apr 16Researchcnio.es

A CNIO group contributes to identifying which breast lesions will progress to cancer, thus helping avoid overtreatment

CNIO (Spain Cancer News)Original source

🌍Apr 16Industrynimbustx.com

Nimbus Therapeutics Presents New Mechanistic Data Highlighting Differentiated Biology of Selective SIK2 Inhibitors at IMMUNOLOGY2026™

Nimbus TherapeuticsOriginal source

🇨🇭Apr 16CDMOsiegfried.ch

Siegfried shareholders approve all proposals at Annual General Meeting 2026

SiegfriedOriginal source

🌍Apr 16Industrytizianalifesciences.com

Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function

Tiziana Life SciencesOriginal source

🇺🇸Apr 16Devicesinvestors.bd.com

BD Earns Industry Top Honors for Transparency, Resiliency and Partnership

Becton Dickinson (BD)Original source

🌍Apr 16Devicesaiforia.com

Aiforia has been selected as an AI partner for the PROSTIA project - expands to five new hospitals in Paris

AiforiaOriginal source

🇮🇹Apr 16Researchhumanitas-research.com

Multifocal liver cancer: distinct biological origins pave the way to Precision Medicine

Humanitas Research Hospital (Milan)Original source

🇸🇪Apr 16CDMOrecipharm.com

CEPI awards seed funding to Analysis Zero to advance real-time RNA vaccine quality testing using NMR technology

Recipharm PressOriginal source

🌍Apr 16universitynews.mit.edu

MIT study reveals a new role for cell membranes

MIT Biology NewsOriginal source

🇯🇵Apr 16Devicessysmex.co.jp

Educational Initiatives for the Next Generation - Implementing Health Education for Elementary School Students and SDGs Education for Junior and Senior High School Students -

Sysmex (Global)Original source

🇯🇵Apr 16CROen.cmicgroup.com

Announcement of Launch in Japan of RAVICTI® Oral Liquid 1.1 g/mL

CMIC Group JapanOriginal source

🇺🇸Apr 16Researchnews.nm.org

Youth Wellness Symposium Offers Parents Tools to Support Children’s Mental Health This Summer

Northwestern MedicineOriginal source

🇺🇸Apr 15Researchbroadinstitute.org

Massive ancient-DNA study reveals natural selection has accelerated in recent human evolution

Broad Institute NewsOriginal source

🇯🇵Apr 15Researchriken.jp

European Parliament delegation visits Wako Campus

RIKENOriginal source

🇺🇸Apr 15CROmedidata.com

The Digital Protocol: What It Is & Why It’s the Future of Clinical Trials

Medidata SolutionsOriginal source

🌍Apr 15Associationkidneyxempowerchallenge.org

KidneyX EMPOWER Prize Challenge

American Society of NephrologyOriginal source

🇬🇧Apr 15Industrygsk.com

GSK completes acquisition of 35Pharma Inc.

GSK NewsOriginal source

🇮🇱Apr 15Industryir.tevapharm.com

Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners

Teva Pharmaceuticals RSSOriginal source

🇺🇸Apr 15CROir.labcorp.com

Labcorp Launches FDA-Cleared Fentanyl Test Delivering Results in 10 Minutes

Labcorp Drug DevelopmentOriginal source

🌍Apr 15Industryalloytx.com

Alloy Therapeutics Announces $40M Series E to Scale Tech-Enabled Biotech Infrastructure

Alloy TherapeuticsOriginal source

🇺🇸Apr 15Researchmdanderson.org

Advances in translational cancer research

MD Anderson Cancer CenterOriginal source

🌍Apr 15Mediaevaluate.com

Meet the Team: Kelly Chamberlain

Evaluate VantageOriginal source

🇨🇭Apr 15Industryinterpharma.ch

Bilaterale III sichern den Erfolgsweg der Schweiz

Interpharma SwitzerlandOriginal source

🌍Apr 15Industrymonashhealth.org

Are your GP details up to date for clinical handover?

Monash HealthOriginal source

🌍Apr 15Industryrss.globenewswire.com

neffy® (epinephrine nasal spray) Approved in Canada as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

ARS PharmaceuticalsOriginal source

🇺🇸Apr 15Researchatlasventure.com

Obsidian Will Go Public Via Merger With Galera And Raise $350m

Atlas VentureOriginal source

🇺🇸Apr 15Researchatlasventure.com

Cell therapy biotech Obsidian leverages Galera reverse merger to go public

Atlas VentureOriginal source

🌍Apr 15Mediaheartsciences.com

HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting

HeartSciencesOriginal source

🇺🇸Apr 15Researchbroadinstitute.org

Cancer Dependency Map Consortium launches Phase 3 to accelerate next-generation therapeutics

Broad Institute NewsOriginal source

🌍Apr 15Industryeledon.com

Transplanting Islet Cells with Piotr Witkowski, MD, PhD

Eledon PharmaceuticalsOriginal source

🌍Apr 15Industryeledon.com

In Vivo’s 2026 Rising Leaders

Eledon PharmaceuticalsOriginal source

🌍Apr 15Researchuab.edu

UAB Medicine expands care with new clinics in first quarter of 2026

University of Alabama at BirminghamOriginal source

🌍Apr 14Industrysellaslifesciences.com

SELLAS Life Sciences - Clinical Biopharmaceutical Company

SELLAS Life SciencesOriginal source

🇯🇵Apr 14Industrytakeda.com

Update on Construction of New Plasma-Derived Therapies Manufacturing Facility in Juso, Osaka | Takeda Pharmaceuticals

Takeda NewsOriginal source

🇯🇵Apr 14Industrytakeda.com

20,000+ Takeda Employees Voted to Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems in 94 countries | Takeda Pharmaceuticals

Takeda NewsOriginal source

🇯🇵Apr 14Industrytakeda.com

Takeda Announces Completion of Acquisition of Own Shares | Takeda Pharmaceuticals

Takeda NewsOriginal source

🇯🇵Apr 14Industrytakeda.com

GAMMAGARD LIQUID ERC Approved for Primary Immunodeficiency

Takeda NewsOriginal source

🇯🇵Apr 14Industrytakeda.com

Filing of Corporate Governance Report to the Tokyo Stock Exchange | Takeda Pharmaceuticals

Takeda NewsOriginal source

🇯🇵Apr 14Industrytakeda.com

Takeda Announces the Pricing Terms of the Previously Announced Cash Tender Offers for Certain Outstanding Notes | Takeda

Takeda NewsOriginal source

🇯🇵Apr 14Industrytakeda.com

Takeda Announces New Assignments of Directors

Takeda NewsOriginal source

🇯🇵Apr 14Industrytakeda.com

Statement on Inadvertent Abstract Disclosure for Oveporexton (TAK-861) by World Sleep Congress

Takeda NewsOriginal source

🇯🇵Apr 14Industrytakeda.com

Takeda Reports Third-Quarter FY2025 Results | Takeda Pharmaceuticals

Takeda NewsOriginal source

🇯🇵Apr 14Industrytakeda.com

Takeda Phase 3 Study Results in Pediatric Ulcerative Colitis

Takeda NewsOriginal source

🇯🇵Apr 14Industrytakeda.com

Rusfertides Phase 3 Trial for Polycythemia Vera at ASCO 2025

Takeda NewsOriginal source

🇯🇵Apr 14Industrytakeda.com

Takeda Presents Long-Term Data from ADVANCE-CIDP 3 Trial of HYQVIA

Takeda NewsOriginal source

🇯🇵Apr 14Industrytakeda.com

Takeda to Hold Third Quarter FY2022 Earnings Call on February 2

Takeda NewsOriginal source

🇯🇵Apr 14Industrytakeda.com

Notice Concerning Withdrawal of Shelf Registration Statement and Filing of New Shelf Registration Statement in Japan

Takeda NewsOriginal source

🇯🇵Apr 14Industrytakeda.com

ADZYNMA® Receives European Commission Approval as First Recombinant ADAMTS13 Therapy for cTTP

Takeda NewsOriginal source

🇯🇵Apr 14Industrytakeda.com

U.S. FDA Approves Takeda’s TAKHZYRO® (lanadelumab-flyo) to Prevent Hereditary Angioedema (HAE) Attacks in Children 2 Years of Age and Older

Takeda NewsOriginal source

🇯🇵Apr 14Industrytakeda.com

Takeda To Acquire Exclusive Worldwide (ex-China) License of HUTCHMED’s Fruquintinib, a Highly Selective, Oral VEGFR1/2/3 Tyrosine Kinase Inhibitor

Takeda NewsOriginal source

🇯🇵Apr 14Industrytakeda.com

Takeda Completes Acquisition of Nimbus Therapeutics’ TYK2 Program Subsidiary

Takeda NewsOriginal source

🇯🇵Apr 14Industrytakeda.com

FDA Accepts Takeda’s Entyvio BLA

Takeda NewsOriginal source

🇺🇸Apr 14Researchbroadinstitute.org

Base editing repairs mutation and liver function in mouse model of Zellweger spectrum disorder

Broad Institute NewsOriginal source

🌍Apr 14Researchpremier-research.com

Strengthening Clinical Trial Operations: Key Priorities for Modern Development

Premier ResearchOriginal source